GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

GlaxoSmithKlin GlaxoSmithKline Pharmaceuticals Ltd. | BSE 2547.00 3.60 (0.14%) | NSE 2559.20 14.90 (0.59%) | Trade | Add

BSE Live

Dec 09, 16:01

2547.00 3.60 (0.14%)

Volume

AVERAGE VOLUME

5-Day

1,997

10-Day

2,159

30-Day

3,048

21,449

Prev. Close

2543.40
Open Price

2527.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 09, 15:56

2559.20 14.90 (0.59%)

Volume

AVERAGE VOLUME

5-Day

103,409

10-Day

90,908

30-Day

95,348

118,147

Prev. Close

2544.30
Open Price

2534.30

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2559.20 (81)

Financials

Print/Copy to Excel : Go

Balance Sheet of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	169.41	169.41	169.41	169.41	169.41
Total Share Capital	169.41	169.41	169.41	169.41	169.41
Reserves and Surplus	1,779.82	1,614.68	1,585.27	2,508.21	1,327.71
Total Reserves and Surplus	1,779.82	1,614.68	1,585.27	2,508.21	1,327.71
Total Shareholders Funds	1,949.23	1,784.09	1,753.00	2,677.62	1,497.12
NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	0.00	0.00
Other Long Term Liabilities	2.49	6.55	4.13	9.67	22.29
Long Term Provisions	248.40	246.21	253.55	260.96	258.25
Total Non-Current Liabilities	250.89	252.76	257.67	270.63	280.54
CURRENT LIABILITIES
Short Term Borrowings	0.00	0.00	0.00	0.00	0.02
Trade Payables	704.01	613.25	418.56	546.63	447.99
Other Current Liabilities	780.40	504.18	480.67	799.75	596.79
Short Term Provisions	416.41	393.52	417.79	327.98	274.62
Total Current Liabilities	1,900.81	1,510.95	1,317.03	1,674.35	1,319.42
Total Capital And Liabilities	4,100.93	3,547.80	3,327.70	4,622.60	3,097.08
ASSETS
NON-CURRENT ASSETS
Tangible Assets	269.54	297.70	294.81	294.95	342.20
Intangible Assets	13.33	23.55	34.09	34.50	43.36
Capital Work-In-Progress	14.32	13.93	20.31	30.50	13.21
Other Assets	0.76	0.00	1.04	1.18	1.33
Fixed Assets	297.95	335.18	350.25	361.13	400.10
Non-Current Investments	24.49	24.49	24.49	24.49	24.49
Deferred Tax Assets [Net]	140.64	145.95	133.18	112.78	101.67
Long Term Loans And Advances	4.00	11.00	88.10	204.60	0.00
Other Non-Current Assets	250.30	56.87	264.96	248.88	399.49
Total Non-Current Assets	717.38	573.49	860.98	951.89	925.75
CURRENT ASSETS
Current Investments	1,118.25	813.22	518.29	365.59	0.00
Inventories	463.17	514.30	437.70	512.71	523.34
Trade Receivables	292.55	222.06	192.38	205.24	215.60
Cash And Cash Equivalents	1,400.89	1,061.20	1,150.73	2,479.11	1,157.68
Short Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
OtherCurrentAssets	108.70	363.53	167.62	108.05	274.71
Total Current Assets	3,383.55	2,974.31	2,466.72	3,670.71	2,171.33
Total Assets	4,100.93	3,547.80	3,327.70	4,622.60	3,097.08
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	487.56	0.00	358.51	365.29	493.24
CIF VALUE OF IMPORTS
Raw Materials	0.00	0.00	0.00	0.00	0.00
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	0.00	0.00	0.00	0.00	0.00
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	799.91	0.00	1,563.00	885.26	1,139.71
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	--	--	--	--	--
Other Earnings	167.68	--	162.17	52.78	27.80
BONUS DETAILS
Bonus Equity Share Capital	125.39	--	125.39	125.39	125.39
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	24.49	--	24.49	24.49	24.49
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--